Clinical trials recruiting in Pella, Iowa
6
Recruiting trials
15
Conditions
Phase breakdown
Phase 3 6
Conditions recruiting in Pella, Iowa
Recruiting trials in Pella, Iowa
- Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- E-Mindfulness Approaches for Living After Breast Cancer
- Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
- Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
- ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
- Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Common questions
How many clinical trials are recruiting in Pella, Iowa?
6 recruiting trials have at least one study site in Pella, Iowa.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.